Abstract:Objectives: Propofol has become the preferred anesthetic in recent years due to its desirable pharmacologic properties. However, propofol possesses a very narrow therapeutic window between the favorable clinical effect and potentially lethal toxicity, therefore, a rapid, simplified, and sensitive liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry (LC-APCI-MS/MS) method is presented in this study for the quantification of propofol in human plasma using the isotope-labeled internal standard (IS) of propofol-d17, and then applied in a bioequivalence study. Materials and methods: Sample preparation was accomplished through simple one-step precipitation of plasma protein with acetonitrile. Chromatographic separation was acquired on an ACE Excel 3 Super C-18 column (2.1 x 50 mm, 3 mu m) using gradient elution at a flow rate of 0.5 mL/min. The MS detection was achieved in the negative ion APCI by multiple reaction monitoring (MRM) mode using the transitions of m/z 177.2 -> 161.0 for propofol and m/z 194.2 -> 174.2 for IS, respectively. 30 healthy Chinese subjects were enrolled in the open-label, randomized, two-period, two-sequence, cross-over bioequivalence study after single-dose intravenous administration of propofol medium-chain triglyceride and long-chain triglyceride (MCT/LCT). Results: The current method was precise and accurate at a linearity range of 4.00 - 1,000 ng/mL without severe interference from the plasma matrix. The inter-and intra-batch precision (2.3 to 15.8%) and accuracy (-4.4 to 3.0%), IS-normalized matrix effect (coefficient of variation <= 4.6%). extraction recovery (107.1 - 117.1%), stability (coefficient of variation <= 8.0%), and dilution integrity were all within the acceptable range. The 90% confidence intervals (CIs) of the ratios of the geometric means (test/reference) were 86.44 - 104.88% for C-max, 96.30 - 104.52% for AUC (0-t), and 96.56 - 105.05% for AUC(0-infinity), which were all within the predefined bioequivalence range of 80 - 125%. Besides, both propofol MCT/LCT preparations were well tolerated in healthy Chinese subjects, and there were no serious adverse events during the study. Conclusion: The method is more simplified and sensitive than the previously reported modes of propofol detection. The two propofol MCT/LCT preparations were considered to be bioequivalent. What is known about this subject - Propofol possesses a very narrow therapeutic window between the favorable clinical effect and potentially lethal toxicity: therefore, a rapid, sensitive, and selective method is required for the determination of propofol. - Various techniques have been reported for the detection of propofol in biological samples. However, most of these methods need cumbersome sample pretreatment processes, such as liquid-liquid extraction, solid-phase extraction, and derivatization, which arc not suitable for the high-throughput analysis of propofol. What this study adds - A novel method that combines sample pretreatment by one-step protein precipitation with LC-APCI-MS/MS analysis for the detection of propofol plasma concentration in healthy Chinese subjects was established and the validated method was applied to a bioequivalence study for the first time. - The fast sample extraction method and a short single run time of 4 minutes make it an attractive procedure in high-throughput analysis of propofol. It also provided the feasibility to quantify plasma concentrations as low as 4.00 ng/mL (LLOQ) for propofol. The method proposed in this study was not only simpler and faster but also more specific and sensitive than other published methods. - Pharmacokinetic parameters of propofol in healthy Chinese subjects were reported for the first time.

Initial pharmacodynamics evaluation of Propofol prodrug HX0891 and HX0892 in the rats

The preclinical pharmacological study on HX0969W, a novel water-soluble pro-drug of propofol, in rats

An Improved Water-Soluble Prodrug of Propofol with High Molecular Utilization and Rapid Onset of Action

Synthesis and characterization of novel quick-release propofol prodrug via lactonization.

[Pharmacokinetics for the solutable type injections of propofol glycoside in rats].

The Hypnotic Synergism among a Water-Soluble Prodrug of Propofol,Midazolam and Fentanyl

Pharmacokinetics and Pharmacodynamics of Propofol Injection in Healthy Volunteers

An Improved Design of Water-Soluble Propofol Prodrugs Characterized by Rapid Onset of Action.

Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats

Efficacy and Safety of Fospropofol(Fd) Compared to Propofol when Given During the Induction of General Anaesthesia: A Phase Ii, Multi-Centre, Randomized, Parallel-Group, Active-Controlled, Double-Blind, Double-Dummy Study

A simplified and sensitive LC-APCI-MS/MS method for the quantification of propofol: Application to a bioequivalence study in healthy Chinese subjects

Design, synthesis, and activity evaluation of water-soluble propofol derivatives as anesthetic drugs

Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol)

Lipid-free Fluoropolymer-based Propofol Emulsions and Lipid Reversal of Propofol Anesthesia in Rats

A systematic review and meta-analysis comparing the efficacy and safety of ciprofol (HSK3486) versus propofol for anesthetic induction and non-ICU sedation

Pharmacodynamics and Pharmacokinetics of HSK3486, a Novel 2,6-Disubstituted Phenol Derivative as a General Anesthetic

Comparison of the Efficacy of HSK3486 and Propofol for Induction of General Anesthesia in Adults: A Multicenter, Randomized, Double-blind, Controlled, Phase 3 Noninferiority Trial

Concentration and regional distribution of propofol in brain and spinal cord during propofol anesthesia in the rat

Fospropofol disodium versus propofol for long-term sedation during invasive mechanical ventilation: A pilot randomized clinical trial

[Fospropofol: A new prodrug of propofol]

The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol